|
A Message from the Founders of
Airway World | |
Dear Friends of Airway World,
As you know, Airway World was designed to help you stay current in the rapidly evolving field of airway management. But did you know that it can also save you time?
Many of you are called upon to provide educational sessions during your monthly faculty or partner meetings, teach residents and students, conduct grand rounds and present to various groups within your practice environment. Instead of spending hours creating a presentation, simply launch Airway World!
You can present one of our recorded webinars or instructional videos. Conduct a review of sentinal articles or recent research. Facilitate a live video chat with a guest speaker from across the country or world. Now that would make for an interesting meeting!
If you have any questions about using Airway World in these ways, please contact Terry T. Steele at tsteele@theairwaysite.com.
Ron M. Walls, MD Michael F. Murphy, MD Robert C. Luten, MD
|
| The Exhibit Hall | |
Visit the Airway World Exhibit Hall to see:
Verathon Medical
KARL STORZ
Clarus Medical
ROTIGS
King Systems
Journal Watch
The Difficult Airway Course
Airway World Visitor Center
Meetings, Seminars & Courses
|
| The Collection | |
Visit The Collection in Airway World to see:
The Anesthesia
Collection
The Emergency Medicine Collection
The Critical Care Collection
The Pediatric Collection
The EMS Collection
The Journal Watch Collection
Airwaves - a blog by Ron M. Walls, MD |
| A Brief Note | |
Dear Airway World Members,
Just a quick note to let you know that the Trauma Airway Review Webinar with Michael A. Gibbs, MD is now posted in the Auditorium. Thank you to those who participated - your questions and comments were great!
I'm sure you've noticed the ROTIGS ad - our first in the Airway World newsletter. Advertising helps us cover our costs so that we can continue to offer free content in Airway World. We'll keep the ads to a minimum and ensure that they are of high quality. Thanks for taking a look at ROTIGS.
Sincerely,
Terry T. Steele
Executive Director
(860) 679-9285
|
|
|
| Airway World Update | | | Be Our Guest |
If you have not yet registered for Airway World, we invite you to be our guest! You can log in directly (without registering) at www.airwayworld.com using these credentials:
Password: awguest1!
This guest log-in will be available until March 11, 2011. After that, we hope you will be inspired to create your own account and begin accessing the live webinars, videos and other great airway resources! It's free and easy! | |
| Schedule of Interactive Events |
| Save the date!
March 8, 2011 3:30 PM EST Airway World Auditorium Quarterly Research Review with Ron M. Walls, MD (webinar) It's easy to stay current in the field of airway management with these quarterly research reviews! Dr. Walls selects the most relevant research from the most recently published, shares the results and discusses their impact on the practice of airway management. Participants may submit questions and comments to Dr. Walls during and after the presentation. Limit 100 participants. March 22, 2011 4:00 PM EST Airway World Auditorium Trauma Airways: Fact, Fiction or In Between with Ali S. Raja, MD (webinar) Join Ali S. Raja, MD, Associate Director for Trauma and attending physician at Brigham and Women's Hospital, as he takes a bold look at the controversies surrounding the management of the trauma airway. Have you ever been told that laryngoscopy is unsafe for trauma patients because of cervical spine motion? What is the supporting evidence for pretreatment agents in patients with suspected brain injury? Is Etomidate safe in polytrauma? Be prepared to support your trauma airway management decisions! Dr. Raja lays out what we know and don't know about airway care of the trauma patient. Participants may submit questions and comments to Dr. Raja during and after the presentation. Limit 100 participants. HOW TO PARTICIPATE: A link to each webinar will be listed in the Airway World Auditorium. Click on the link when it becomes live 30 minutes before the start of the program. You will be taken to the webinar where you will enter your name and email address to join the session. Would you like an Outlook reminder? Click on the Outlook icon near the webinar link in Airway World. |
|
|
Airway World Spotlight: The Journal Watch Collection |
| |
Have you heard of Journal Watch? Journal Watch is a service offered by the publishers of the New England Journal of Medicine to help physicians and allied heath professionals save time and stay informed by providing brief, clearly written, clinically focused perspectives on the medical developments that affect practice.
Journal Watch Physician Editorial Boards survey the medical literature, select the most important research and guidelines, distill them into focused summaries, and frame them in a clinical context.
We are very fortunate to receive the airway-related Journal Watch summaries each month. You will find them in The Journal Watch Collection in Airway World. Archived summaries are also there. See below for a complimentary Journal Watch summary. 
|
| Complimentary Journal Watch Summary & Comment |
| |
Etomidate or Midazolam for Rapid Sequence Induction in Patients with Suspected Sepsis?
Outcomes did not differ significantly with the two induction agents.
Despite studies showing no increase in adverse outcomes related to etomidate induction for intubation of patients with shock (JW Emerg Med Jul 2 2009 and JW Emerg Med Feb 13 2009), some clinicians still oppose its use in such patients. In this prospective, double-blind, randomized trial, 122 adult patients who presented to a single emergency department with suspected sepsis and indication for intubation received either midazolam (0.1 mg/kg) or etomidate (0.3 mg/kg) for induction. Sepsis was confirmed in 96 patients who had clear evidence of infection and fulfilled two of four criteria for systemic inflammatory response syndrome.
The midazolam and etomidate groups demonstrated no significant differences in median hospital length of stay (LOS) (9.5 and 7.3 days), median intensive care unit LOS (4.2 and 3.1 days), median ventilator days (2.8 and 2.1 days), or inhospital mortality (21% and 26%). Subgroup analysis of patients who survived to discharge also showed no difference in median hospital LOS between midazolam and etomidate recipients (11.3 and 11.8 days).
Comment: In this study, use of a single bolus of etomidate for induction in patients with sepsis was not associated with any deleterious outcomes. Etomidate is an ideal induction agent because of its predictable dosing, rapid onset, short duration of action, and excellent hemodynamic stability. This report adds to a growing body of well-designed studies that refute the assertion that etomidate should not be used in patients with sepsis.
- Richard D. Zane, MD, FAAEM
Published in Journal Watch Emergency Medicine December 17, 2010
Citation(s):
Tekwani KL et al. A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: A prospective, randomized study. Ann Emerg Med 2010 Nov; 56:481.
Copyright © 2010. Massachusetts Medical Society. All rights reserved. |
|
Advertisement
|
| |
|
|
|
